{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T11:00:27Z","timestamp":1753182027952,"version":"3.37.3"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Scientific Research of Japan Society","award":["20K08788"],"award-info":[{"award-number":["20K08788"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,19]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Hydroxychloroquine (HCQ) is effective for treating a number of autoimmune diseases, including systemic lupus erythematosus. HCQ is generally safe and may be prescribed to pregnant women. Although current guidelines recommend initiating HCQ when considering pregnancy, the drug can cause adverse effects such as acute generalised exanthematous pustulosis (AGEP), which should be carefully evaluated. A 30-year-old pregnant woman with systemic lupus erythematosus at 16\u2009+\u20095 gestational weeks was referred to National Center for Child Health and Development for persistent proteinuria and alopecia. Tacrolimus was initiated, and the dose of prednisone was increased. At 20\u2009+\u20093\u2009weeks of gestation, HCQ was administered to allow for a dose reduction of prednisolone. Proteinuria gradually improved as the pregnancy course stabilised. At 27\u2009+\u20091\u2009weeks of gestation, generalised pustular exanthema developed, presumably due to HCQ. Based on the clinical course and the analysis of the skin lesions, she was diagnosed to have either AGEP or generalised pustular psoriasis. Despite discontinuing HCQ, the skin lesions worsened dramatically, and infliximab therapy was required. After one course of infliximab treatment, exanthema gradually subsided. The final diagnosis was AGEP, based on the clinical course and pathological findings. At 30\u2009weeks, pyothorax developed because of the pyogenic skin lesion and the compromised immune system, and long-term antibiotic therapy was required until 32\u2009+\u20094\u2009weeks, after which she underwent caesarean section. Although introducing HCQ is occasionally necessary during pregnancy, it is preferable to initiate HCQ in the preconception period and not after pregnancy because of the possible adverse effect, which can alter perinatal prognosis. Rheumatologists should consider the potential risks of HCQ.<\/jats:p>","DOI":"10.1093\/mrcr\/rxac089","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T12:10:13Z","timestamp":1669291813000},"page":"373-377","source":"Crossref","is-referenced-by-count":2,"title":["Initiation of hydroxychloroquine therapy during pregnancy can cause adverse effects and alter pregnancy outcomes: A case of acute generalised exanthematous pustulosis induced by hydroxychloroquine in a patient with systemic lupus erythematosus"],"prefix":"10.1093","volume":"7","author":[{"given":"Kotoi","family":"Tsurane","sequence":"first","affiliation":[{"name":"Division of Obstetrics, Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development , Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3411-5896","authenticated-orcid":false,"given":"Kayoko","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Division of Maternal Medicine, Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development , Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazue","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Division of Dermatology, National Center for Child Health and Development , Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Division of Dermatology, National Center for Child Health and Development , Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhiko","family":"Sago","sequence":"additional","affiliation":[{"name":"Division of Obstetrics, Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development , Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Murashima","sequence":"additional","affiliation":[{"name":"Division of Maternal Medicine, Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development , Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,11,24]]},"reference":[{"key":"2023061920012690500_R1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.41191","article-title":"2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2023061920012690500_R2","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.clinthera.2008.05.014","article-title":"Acute generalized exanthematous pustulosis induced by hydroxychloroquine: three cases and a review of the literature","volume":"30","author":"Paradisi","year":"2008","journal-title":"Clin Ther"},{"key":"2023061920012690500_R3","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/ijd.15419","article-title":"Hydroxychloroquine-induced acute generalized exanthematous pustulosis: a series of seven patients and review of the literature","volume":"60","author":"Chaabouni","year":"2021","journal-title":"Int J Dermatol"},{"key":"2023061920012690500_R4","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107093","article-title":"Acute generalized exanthematous pustulosis with a focus on hydroxychloroquine: a 10-year experience in a skin hospital","volume":"89","author":"Nili","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"2023061920012690500_R5","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5801280","article-title":"Impetigo herpetiformis: review of pathogenesis, complication, and treatment","volume":"2018","author":"Namazi","year":"2018","journal-title":"Dermatol Res Pract"},{"key":"2023061920012690500_R6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1034\/j.1600-0560.2001.028003113.x","article-title":"Acute generalized exanthematous pustulosis (AGEP)\u2014a clinical reaction pattern","volume":"28","author":"Sidoroff","year":"2001","journal-title":"J Cutan Pathol"},{"key":"2023061920012690500_R7","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13565","article-title":"Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine","volume":"33","author":"Litaiem","year":"2020","journal-title":"Dermatol Ther"},{"key":"2023061920012690500_R8","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1016\/j.jaip.2020.05.046","article-title":"Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19","volume":"8","author":"Delaleu","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2023061920012690500_R9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-1-4939-0597-3_2","volume-title":"Hydroxychloroquine and Chloroquine Retinopathy","author":"Browning","year":"2014"},{"key":"2023061920012690500_R10","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jaad.2015.07.017","article-title":"Acute generalized exanthematous pustulosis (AGEP): a review and update","volume":"73","author":"Szatkowski","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"2023061920012690500_R11","first-page":"212","article-title":"Prolonged pustular eruption from hydroxychloroquine: an unusual case of acute generalized exanthematous pustulosis","volume":"97","author":"Pearson","year":"2016","journal-title":"Cutis"},{"key":"2023061920012690500_R12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00130832-200208000-00006","article-title":"Acute generalized exanthematous pustulosis, a clue to neutrophil-mediated inflammatory processes orchestrated by T cells","volume":"2","author":"Britschgi","year":"2002","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"2023061920012690500_R13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/120347540300700102","article-title":"Do the physical and histologic features and time course in acute generalized exanthematous pustulosis reflect a pattern of cytokine dysregulation?","volume":"7","author":"Smith","year":"2003","journal-title":"J Cutan Med Surg"},{"key":"2023061920012690500_R14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1468-3083.2006.02026.x","article-title":"Overlap of acute generalized exanthematous pustulosis and toxic epidermal necrolysis: response to antitumour necrosis factor-alpha antibody infliximab: report of three cases","volume":"21","author":"Meiss","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2023061920012690500_R15","doi-asserted-by":"crossref","DOI":"10.1016\/j.siny.2020.101146","article-title":"The fetal inflammatory response syndrome: the origins of a concept, pathophysiology, diagnosis, and obstetrical implications","volume":"25","author":"Jung","year":"2020","journal-title":"Semin Fetal Neonatal Med"},{"key":"2023061920012690500_R16","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-021-00782-3","article-title":"Extracellular vesicles from maternal uterine cells exposed to risk factors cause fetal inflammatory response","volume":"19","author":"Shepherd","year":"2021","journal-title":"Cell Commun Signal"},{"key":"2023061920012690500_R17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.anai.2020.08.002","article-title":"The infectious complications of atopic dermatitis","volume":"126","author":"Wang","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2023061920012690500_R18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ijgo.12833","article-title":"Maternal sepsis is an evolving challenge","volume":"146","author":"Turner","year":"2019","journal-title":"Int J Gynecol Obstet"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxac089\/47997933\/rxac089.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/7\/2\/373\/50646580\/rxac089.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/7\/2\/373\/50646580\/rxac089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T17:19:44Z","timestamp":1701451184000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/7\/2\/373\/6845429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,24]]},"references-count":18,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,11,24]]},"published-print":{"date-parts":[[2023,6,19]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxac089","relation":{},"ISSN":["2472-5625"],"issn-type":[{"type":"electronic","value":"2472-5625"}],"subject":[],"published-other":{"date-parts":[[2023,7,1]]},"published":{"date-parts":[[2022,11,24]]}}}